May 22, 2026

BARDA seeks info on Phase 2+ antifungals for Candida and Aspergillus

Dear All: As discussed in prior newsletters, BARDA is constantly working to ensure it has adequate medical countermeasures (MCMs) for a variety of possible threats. The titles of these newsletters give a quick review of their recent work — note in particular the Fireside Chat and the newsletter discussing the ongoing BAA (Broad Agency Announcement)

Read More »
Scroll to Top